What is the Org number of Lillestrøm Legesenter AS?

Lillestrøm Legesenter AS is registered with Brønnøysundsregistrene under Org 921966237.

What is the revenue of Lillestrøm Legesenter AS?

Lillestrøm Legesenter AS reported revenue of 7,7 mill. kr in 2025.

Lillestrøm Legesenter AS employs 5 people as of the latest annual report.

Kristin Sundby Myhrer is the CEO of Lillestrøm Legesenter AS, in role since 2020.

Marius Ryengen chairs the board of Lillestrøm Legesenter AS, in role since 2022.

Lillestrøm Legesenter AS's registered address is C.J. Hansens Vei 13, 2007 Kjeller.

ASActive

Org 921966237C.J. Hansens Vei 13, 2007 KjellerGeneral medical practice activities· NACE 8621Est. 2018 · 7 years old5 employees

Actively employed in the business

Name	Role	Member since
Current (1)
KS Kristin Sundby Myhrer Chief Executive Officer	Chief Executive Officer	2020

Non-executive oversight

Name	Role	Member since
Current (8)
KS Kristin Sundby Myhrer Board of Directors	Board of Directors	2022
HM Hans-Christian Myklestul Board of Directors	Board of Directors	2022
LG Lene Gjelseth Dalbak Board of Directors	Board of Directors	2022
SM Signe Marie Rambøl Alme Board of Directors	Board of Directors	2022
KS Katrine Sæves Board of Directors	Board of Directors	2022
MR Marius Ryengen Chairman	Chairman	2022
TL Trine Livik Haugen Board of Directors	Board of Directors	2022
SB Siri Bækkelund Engen Board of Directors	Board of Directors	2022

Former (1)


SA Sture André Rognstad Board of Directors	Board of Directors	2020 – 2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Kristin Sundby Myhrer	Individual	12.5%	12.5%	2025
Hans-Christian Myklestul	Individual	12.5%	12.5%	2025
Lene Gjelseth Dalbak	Individual	12.5%	12.5%	2025
Signe Marie Rambøl Alme	Individual	12.5%	12.5%	2025
Katrine Sæves	Individual	12.5%	12.5%	2025
Marius Ryengen	Individual	12.5%	12.5%	2025
Trine Livik Haugen	Individual	12.5%	12.5%	2025
Siri Bækkelund Engen	Individual	12.5%	12.5%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.